Erratum to: Diabetologia

DOI 10.1007/s00125-014-3396-4

The authors wish to point out a typographical error in the penultimate paragraph of this research letter. The second main observation of the research was that treatment with empagliflozin for 8 weeks increased RA (not decreased).

Unfortunately, the x-axes for Fig. 1a–d were labelled incorrectly and did not distinguish between participants with normofiltration (T1D-N) or hyperfiltration (T1D-H); the corrected figure is shown overleaf:

figure a